Chad J. Kolean
2023
In 2023, Chad J. Kolean earned a total compensation of $1.1M as Chief Financial Officer at Cellectar Biosciences, a 140% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $234,000 |
|---|---|
| Option Awards | $284,960 |
| Salary | $390,000 |
| Stock Awards | $112,770 |
| Other | $87,230 |
| Total | $1,108,960 |
Kolean received $390K in salary, accounting for 35% of the total pay in 2023.
Kolean also received $234K in non-equity incentive plan, $285K in option awards, $112.8K in stock awards and $87.2K in other compensation.
Rankings
In 2023, Chad J. Kolean's compensation ranked 1,089th out of 2,918 executives tracked by ExecPay. In other words, Kolean earned more than 62.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,089 out of 2,918 | 63rd |
Division Manufacturing | 651 out of 1,608 | 60th |
Major group Chemicals And Allied Products | 445 out of 901 | 51st |
Industry group Drugs | 434 out of 864 | 50th |
Industry Pharmaceutical Preparations | 297 out of 622 | 52nd |
Source: SEC filing on April 26, 2024.
Kolean's colleagues
We found two more compensation records of executives who worked with Chad J. Kolean at Cellectar Biosciences in 2023.